Shilpa Medicare Limited Recalls

Understanding this recall history

This page summarizes recall records in which the official source identifies Shilpa Medicare Limited as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.

Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.

Recall history in this database

PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial recall — FDA D-0764-2026

PEMRYDI RTU(pemetrexed injection), 500 mg/50 mL (10 mg/mL), Single-dose vial recall — FDA D-0765-2026

Azacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only recall — FDA D-0122-2021

Shilpa Medicare Docetaxel Injection USP 160 mg/8mL (20 mg/mL), For Intravenous Infusion Only recall — FDA D-0126-2021

Shilpa Medicare Busulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only recall — FDA D-0121-2021

Understanding this recall history